STING signaling is suppressed in several cancers, including melanoma (25), colon cancer (26), and KRAS/LKB1–mutant lung cancer, perhaps as a consequence of STING’s role in antitumor immunity and sensing of DNA damage (17). This evidence concerns the gene KRAS and lung carcinoma.